Cargando…

External validation of (18)F-FDG PET-based radiomic models on identification of residual oesophageal cancer after neoadjuvant chemoradiotherapy

Detection of residual oesophageal cancer after neoadjuvant chemoradiotherapy (nCRT) is important to guide treatment decisions regarding standard oesophagectomy or active surveillance. The aim was to validate previously developed (18)F-FDG PET-based radiomic models to detect residual local tumour and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valkema, Maria J., Beukinga, Roelof J., Chatterjee, Avishek, Woodruff, Henry C., van Klaveren, David, Noordzij, Walter, Valkema, Roelf, Bennink, Roel J., Roef, Mark J., Schreurs, Wendy, Doukas, Michail, Lagarde, Sjoerd M., Wijnhoven, Bas P.L., Lambin, Philippe, Plukker, John T.M., van Lanschot, J. Jan B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337315/ https://www.ncbi.nlm.nih.gov/pubmed/37132272 http://dx.doi.org/10.1097/MNM.0000000000001707

Ejemplares similares

The effectiveness of neoadjuvant chemoradiotherapy in oesophageal adenocarcinoma with presence of extracellular mucin, signet‐ring cells, and/or poorly cohesive cells
por: Valkema, Maria J, et al.
Publicado: (2023)

A prospective cohort study on active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer: protocol of Surgery As Needed for Oesophageal cancer-2
por: van der Zijden, Charlène J., et al.
Publicado: (2023)

The effectivity of targeted therapy and immunotherapy in patients with advanced metastatic and non-metastatic cancer of the esophagus and esophago-gastric junction
por: Valkema, M. J., et al.
Publicado: (2022)

Neoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer: a stepped-wedge cluster randomised trial
por: Noordman, Bo Jan, et al.
Publicado: (2018)

Active surveillance of oesophageal cancer after response to neoadjuvant chemoradiotherapy: dysphagia is uncommon
por: Valkema, Maria J, et al.
Publicado: (2023)

Detection of circulating tumour DNA after neoadjuvant chemoradiotherapy in patients with locally advanced oesophageal cancer
por: Eyck, Ben M, et al.
Publicado: (2022)

Shrinkage versus fragmentation response in neoadjuvantly treated oesophageal adenocarcinoma: significant prognostic relevance
por: Graham Martinez, Cristina, et al.
Publicado: (2022)

Updated protocol of the SANO trial: a stepped-wedge cluster randomised trial comparing surgery with active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancer
por: Eyck, Ben M., et al.
Publicado: (2021)

Cardiac stress imaging for the prediction of very long-term outcomes: Dobutamine stress echocardiography or dobutamine (99m)Tc-sestamibi SPECT?
por: Boiten, Hendrik J., et al.
Publicado: (2016)

Positive [(18)F]fluoroethyltyrosine PET/MRI in suspected recurrence of growth hormone–producing pituitary adenoma in a paediatric patient
por: Veldhuijzen van Zanten, Sophie E. M., et al.
Publicado: (2021)

Residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer: locations undetected by endoscopic biopsies in the preSANO trial
por: van der Wilk, B. J., et al.
Publicado: (2020)

Does tumescent liposuction damage the lymph vessels in lipoedema patients?
por: van de Pas, Chantalle B, et al.
Publicado: (2019)

Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study
por: Zhang, Xiaobin, et al.
Publicado: (2020)

Pattern of recurrence in patients with a pathologically complete response after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer
por: de Jongh, M, et al.
Publicado: (2021)

Met expression is an independent prognostic risk factor in patients with oesophageal adenocarcinoma
por: Tuynman, J B, et al.
Publicado: (2008)

15-Year outcome after normal exercise (99m)Tc-sestamibi myocardial perfusion imaging: What is the duration of low risk after a normal scan?
por: Schinkel, Arend F. L., et al.
Publicado: (2012)

Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: multicentre East Asian and Dutch database comparison
por: Eyck, Ben M, et al.
Publicado: (2022)

Do pathologists agree with each other on the histological assessment of pT1b oesophageal adenocarcinoma?
por: Gotink, Annieke W, et al.
Publicado: (2018)

Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [(111)In-DOTA]MG11—first estimates for clinical translation
por: Kaloudi, Aikaterini, et al.
Publicado: (2016)

Long-term prognostic value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography
por: Boiten, Hendrik J., et al.
Publicado: (2012)

ICG‐fluorescence angiography assessment of colon interposition for oesophageal cancer – A Video Vignette
por: Galema, Hidde A., et al.
Publicado: (2022)

Chemotherapy aNd chemoradiotherapy for adenocarcinoma of the OESophagus and esophagogastric junction with oligometastases: Protocol of the TNT-OES-1 trial
por: van der Zijden, Charlène J., et al.
Publicado: (2022)

Loss of SRY‐box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma
por: ten Kate, F. J. C., et al.
Publicado: (2017)

Patient preferences for active surveillance vs standard surgery after neoadjuvant chemoradiotherapy in oesophageal cancer treatment: The NOSANO‐study
por: Hermus, Merel, et al.
Publicado: (2022)

Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: Long-term results of a randomized controlled trial
por: Boonstra, Jurjen J, et al.
Publicado: (2011)

Positron emission tomography for staging of oesophageal and gastroesophageal malignancy.
por: Kole, A. C., et al.
Publicado: (1998)

Molecular imaging of inflammation and intraplaque vasa vasorum: A step forward to identification of vulnerable plaques?
por: ten Kate, Gerrit L., et al.
Publicado: (2010)

Characteristics Predicting Short-Term and Long-Term Health-Related Quality of Life in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy and Esophagectomy
por: van der Wilk, Berend J., et al.
Publicado: (2023)

Prediction of Non-Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients with (18)F-FDG PET Radiomics Based Machine Learning Classification
por: Beukinga, Roelof J., et al.
Publicado: (2022)

Pattern of p53 protein expression is predictive for survival in chemoradiotherapy-naive esophageal adenocarcinoma
por: Ten Kate, Fiebo J.C., et al.
Publicado: (2017)

International benchmarking in oesophageal and gastric cancer surgery
por: Busweiler, L. A. D., et al.
Publicado: (2018)

Transhiatal vs extended transthoracic resection in oesophageal carcinoma: patients' utilities and treatment preferences
por: de Boer, A G E M, et al.
Publicado: (2002)

Early onset esophageal adenocarcinoma: a distinct molecular entity?
por: van Nistelrooij, Anna M.J., et al.
Publicado: (2016)

Correction: Rijnsdorp et al. Impact of the Noise Penalty Factor on Quantification in Bayesian Penalized Likelihood (Q.Clear) Reconstructions of (68)Ga-PSMA PET/CT Scans. Diagnostics 2021, 11, 847
por: Rijnsdorp, Sjoerd, et al.
Publicado: (2021)

Impact of the Noise Penalty Factor on Quantification in Bayesian Penalized Likelihood (Q.Clear) Reconstructions of (68)Ga-PSMA PET/CT Scans
por: Rijnsdorp, Sjoerd, et al.
Publicado: (2021)

The Impact of Signet Ring Cell Differentiation on Outcome in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma
por: van Hootegem, Sander J. M., et al.
Publicado: (2019)

Limitations of Only Reporting the Odds Ratio in the Age of Precision Medicine: A Deterministic Simulation Study
por: Chatterjee, Avishek, et al.
Publicado: (2021)

Patients’ perception of diagnostic tests in the preoperative assessment of esophageal cancer
por: Westerterp, Marinke, et al.
Publicado: (2008)

Population-based study of treatment and outcome of recurrent oesophageal or junctional cancer
por: Pape, Marieke, et al.
Publicado: (2022)

Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?
por: Schreurs, L. M. A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_k277bbu50rcgidvl0616brbi62